Загрузка...
Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
The coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2, has recently emerged worldwide. In this context, there is an urgent need to identify safe and effective therapeutic strategies for treatment of such highly contagious disease. We recent...
Сохранить в:
| Опубликовано в: : | Microb Drug Resist |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Mary Ann Liebert, Inc., publishers
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7987362/ https://ncbi.nlm.nih.gov/pubmed/33729874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/mdr.2020.0232 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|